Comparison of Fludarabine Versus Bendamustine as a Lymphodepleting Chemotherapy Prior to CAR-T for Large Cell Lymphoma
Study #: CT23-01
Study Status: Published
Presentation(s)
2024, ASH (Oral)
Comparison of fludarabine versus bendamustine as a lymphodepleting chemotherapy prior to CAR‑T for large cell lymphoma.
Citation
Ahmed N, Ali A, Kim S, Oloyede T, Bye M, Gowda L, Kamble RT, Mirza AS, Nadiminti KV, Pophali PA, Rodriguez-Bonilla C, Sieg A, Strouse C, Abid AB, Afrough A, Aljurf M, Beitinjaneh AM, Chhabra S, Choe M, Hillal T, Iqbal M, Jain T, Kharfan-Dabaja MA, Modi D, Orti G, Pawarode A, Rao U, Riedell PA, Saad A, Seo S, Balari AS, Wagner JL, Wudhikarn K, Turtle CJ, Phillips CL, Pasquini MC, Ahmed S, Ganguly S, Moskop A.
Transplantation and Cellular Therapy. 2026, Jun 24: S2666-6367(26): S2666-6367(26):00510-5. doi: 10.1016/j.jtct.2026.06.035. Epub 2026, Jun 24. PMCID:.
PubMed
PMID: 42341926
Abstract
